SYENSQO SA (SYENS.BR) Stock Fundamental Analysis

EBR:SYENS • BE0974464977

80 EUR
-0.82 (-1.01%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Overall SYENS gets a fundamental rating of 3 out of 10. We evaluated SYENS against 69 industry peers in the Chemicals industry. SYENS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SYENS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year SYENS was profitable.
  • In the past year SYENS had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: SYENS reported negative net income in multiple years.
  • SYENS had a positive operating cash flow in each of the past 5 years.
SYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFSYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.38%, SYENS is doing worse than 65.75% of the companies in the same industry.
  • SYENS's Return On Equity of -0.70% is on the low side compared to the rest of the industry. SYENS is outperformed by 65.75% of its industry peers.
  • SYENS has a Return On Invested Capital (3.97%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SYENS is in line with the industry average of 7.09%.
  • The last Return On Invested Capital (3.97%) for SYENS is well below the 3 year average (8.47%), which needs to be investigated, but indicates that SYENS had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.38%
ROE -0.7%
ROIC 3.97%
ROA(3y)2.81%
ROA(5y)0.13%
ROE(3y)7.26%
ROE(5y)-1.97%
ROIC(3y)8.47%
ROIC(5y)7.63%
SYENS.BR Yearly ROA, ROE, ROICSYENS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

  • SYENS has a Operating Margin (8.58%) which is in line with its industry peers.
  • SYENS's Operating Margin has declined in the last couple of years.
  • The Gross Margin of SYENS (30.40%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of SYENS has remained more or less at the same level.
Industry RankSector Rank
OM 8.58%
PM (TTM) N/A
GM 30.4%
OM growth 3Y-4.48%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5YN/A
SYENS.BR Yearly Profit, Operating, Gross MarginsSYENS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SYENS is creating some value.
  • SYENS has less shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, SYENS has an improved debt to assets ratio.
SYENS.BR Yearly Shares OutstandingSYENS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SYENS.BR Yearly Total Debt VS Total AssetsSYENS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • SYENS has an Altman-Z score of 2.34. This is not the best score and indicates that SYENS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of SYENS (2.34) is comparable to the rest of the industry.
  • The Debt to FCF ratio of SYENS is 9.54, which is on the high side as it means it would take SYENS, 9.54 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 9.54, SYENS perfoms like the industry average, outperforming 56.16% of the companies in the same industry.
  • SYENS has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of SYENS (0.42) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 9.54
Altman-Z 2.34
ROIC/WACC0.56
WACC7.07%
SYENS.BR Yearly LT Debt VS Equity VS FCFSYENS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 2.34 indicates that SYENS has no problem at all paying its short term obligations.
  • SYENS has a Current ratio of 2.34. This is in the better half of the industry: SYENS outperforms 78.08% of its industry peers.
  • SYENS has a Quick Ratio of 1.62. This is a normal value and indicates that SYENS is financially healthy and should not expect problems in meeting its short term obligations.
  • SYENS has a better Quick ratio (1.62) than 75.34% of its industry peers.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 1.62
SYENS.BR Yearly Current Assets VS Current LiabilitesSYENS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for SYENS have decreased strongly by -325.13% in the last year.
  • Looking at the last year, SYENS shows a very negative growth in Revenue. The Revenue has decreased by -22.70% in the last year.
  • Measured over the past years, SYENS shows a small growth in Revenue. The Revenue has been growing by 4.31% on average per year.
EPS 1Y (TTM)-325.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30.97%
Revenue 1Y (TTM)-22.7%
Revenue growth 3Y4.31%
Revenue growth 5YN/A
Sales Q2Q%-7.1%

3.2 Future

  • Based on estimates for the next years, SYENS will show a small growth in Earnings Per Share. The EPS will grow by 4.07% on average per year.
  • Based on estimates for the next years, SYENS will show a small growth in Revenue. The Revenue will grow by 0.27% on average per year.
EPS Next Y-13.26%
EPS Next 2Y-0.07%
EPS Next 3Y5.14%
EPS Next 5Y4.07%
Revenue Next Year-4.19%
Revenue Next 2Y-1.79%
Revenue Next 3Y0.22%
Revenue Next 5Y0.27%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SYENS.BR Yearly Revenue VS EstimatesSYENS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
SYENS.BR Yearly EPS VS EstimatesSYENS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 24.62, the valuation of SYENS can be described as rather expensive.
  • SYENS's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of SYENS to the average of the S&P500 Index (26.68), we can say SYENS is valued inline with the index average.
  • A Price/Forward Earnings ratio of 15.20 indicates a correct valuation of SYENS.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SYENS indicates a somewhat cheap valuation: SYENS is cheaper than 68.49% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of SYENS to the average of the S&P500 Index (28.06), we can say SYENS is valued slightly cheaper.
Industry RankSector Rank
PE 24.62
Fwd PE 15.2
SYENS.BR Price Earnings VS Forward Price EarningsSYENS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 69.86% of the companies in the same industry are more expensive than SYENS, based on the Enterprise Value to EBITDA ratio.
  • 64.38% of the companies in the same industry are more expensive than SYENS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 26.73
EV/EBITDA 7.6
SYENS.BR Per share dataSYENS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.07%
EPS Next 3Y5.14%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. Dividend

5.1 Amount

  • SYENS has a Yearly Dividend Yield of 1.40%.
  • Compared to an average industry Dividend Yield of 2.15, SYENS has a dividend in line with its industry peers.
  • SYENS's Dividend Yield is slightly below the S&P500 average, which is at 1.84.
Industry RankSector Rank
Dividend Yield 1.4%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
SYENS.BR Yearly Dividends per shareSYENS.BR Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5

5.3 Sustainability

  • SYENS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-387.23%
EPS Next 2Y-0.07%
EPS Next 3Y5.14%
SYENS.BR Yearly Income VS Free CF VS DividendSYENS.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 500M -500M -1B

More info and screens

Find the best dividend stocksShow peers with best dividend

SYENSQO SA

EBR:SYENS (2/13/2026, 7:00:00 PM)

80

-0.82 (-1.01%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06
Earnings (Next)02-26
Inst Owners33.61%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.31B
Revenue(TTM)6.54B
Net Income(TTM)-47.00M
Analysts79.29
Price Target80.95 (1.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.4%
Yearly Dividend1.63
Dividend Growth(5Y)N/A
DP-387.23%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-37.09%
Min EPS beat(2)-59.05%
Max EPS beat(2)-15.13%
EPS beat(4)0
Avg EPS beat(4)-29.41%
Min EPS beat(4)-59.05%
Max EPS beat(4)-4.8%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.49%
Min Revenue beat(2)-4.63%
Max Revenue beat(2)-4.35%
Revenue beat(4)0
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-4.63%
Max Revenue beat(4)-1.3%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.35%
PT rev (3m)-2.01%
EPS NQ rev (1m)0.96%
EPS NQ rev (3m)-32.13%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.9%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-2.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.98%
Valuation
Industry RankSector Rank
PE 24.62
Fwd PE 15.2
P/S 1.27
P/FCF 26.73
P/OCF 9.54
P/B 1.23
P/tB 2.92
EV/EBITDA 7.6
EPS(TTM)3.25
EY4.06%
EPS(NY)5.26
Fwd EY6.58%
FCF(TTM)2.99
FCFY3.74%
OCF(TTM)8.38
OCFY10.48%
SpS62.9
BVpS64.79
TBVpS27.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number68.83
Profitability
Industry RankSector Rank
ROA -0.38%
ROE -0.7%
ROCE 5.3%
ROIC 3.97%
ROICexc 4.57%
ROICexgc 7.9%
OM 8.58%
PM (TTM) N/A
GM 30.4%
FCFM 4.76%
ROA(3y)2.81%
ROA(5y)0.13%
ROE(3y)7.26%
ROE(5y)-1.97%
ROIC(3y)8.47%
ROIC(5y)7.63%
ROICexc(3y)9.08%
ROICexc(5y)8.08%
ROICexgc(3y)19%
ROICexgc(5y)18.92%
ROCE(3y)11.29%
ROCE(5y)10.17%
ROICexgc growth 3Y-19.3%
ROICexgc growth 5YN/A
ROICexc growth 3Y-9.3%
ROICexc growth 5YN/A
OM growth 3Y-4.48%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5YN/A
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 9.54
Debt/EBITDA 2.2
Cap/Depr 76.09%
Cap/Sales 8.57%
Interest Coverage 250
Cash Conversion 67.16%
Profit Quality N/A
Current Ratio 2.34
Quick Ratio 1.62
Altman-Z 2.34
F-Score4
WACC7.07%
ROIC/WACC0.56
Cap/Depr(3y)98.43%
Cap/Depr(5y)76.05%
Cap/Sales(3y)9.47%
Cap/Sales(5y)8.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-325.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30.97%
EPS Next Y-13.26%
EPS Next 2Y-0.07%
EPS Next 3Y5.14%
EPS Next 5Y4.07%
Revenue 1Y (TTM)-22.7%
Revenue growth 3Y4.31%
Revenue growth 5YN/A
Sales Q2Q%-7.1%
Revenue Next Year-4.19%
Revenue Next 2Y-1.79%
Revenue Next 3Y0.22%
Revenue Next 5Y0.27%
EBIT growth 1Y-17.5%
EBIT growth 3Y-0.36%
EBIT growth 5YN/A
EBIT Next Year39.39%
EBIT Next 3Y17.85%
EBIT Next 5Y11.57%
FCF growth 1Y-48.94%
FCF growth 3Y-7.48%
FCF growth 5YN/A
OCF growth 1Y-34.04%
OCF growth 3Y7.55%
OCF growth 5YN/A

SYENSQO SA / SYENS.BR FAQ

What is the ChartMill fundamental rating of SYENSQO SA (SYENS.BR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to SYENS.BR.


Can you provide the valuation status for SYENSQO SA?

ChartMill assigns a valuation rating of 4 / 10 to SYENSQO SA (SYENS.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for SYENSQO SA?

SYENSQO SA (SYENS.BR) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for SYENS stock?

The Price/Earnings (PE) ratio for SYENSQO SA (SYENS.BR) is 24.62 and the Price/Book (PB) ratio is 1.23.


Can you provide the expected EPS growth for SYENS stock?

The Earnings per Share (EPS) of SYENSQO SA (SYENS.BR) is expected to decline by -13.26% in the next year.